Literature DB >> 6780640

Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease.

J Over, J J Sixma, B N Bouma, P A Bolhuis, R A Vlooswijk, N H Beeser-Visser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6780640

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  4 in total

1.  Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome.

Authors:  D B Rubin; J P Wiener-Kronish; J F Murray; D R Green; J Turner; J M Luce; A B Montgomery; J D Marks; M A Matthay
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A.

Authors:  Qizhen Shi; Scot A Fahs; Erin L Kuether; Brian C Cooley; Hartmut Weiler; Robert R Montgomery
Journal:  Blood       Date:  2010-07-06       Impact factor: 22.113

3.  The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.

Authors:  A Leyte; J Voorberg; H B Van Schijndel; B Duim; H Pannekoek; J A Van Mourik
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

4.  The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII.

Authors:  A Leyte; M P Verbeet; T Brodniewicz-Proba; J A Van Mourik; K Mertens
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.